17.23
price down icon0.86%   -0.15
after-market Dopo l'orario di chiusura: 17.18 -0.05 -0.29%
loading

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
750.30%
568.44
66.85 65.82 58.11 59.78
Nonoperating Income/Loss
30.70%
2.729
3.938 13.10 2.124 -0.768
Income/Loss From Continuing Operations Before Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Income/Loss From Continuing Operations After Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Net Income/Loss
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Diluted Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Basic Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Diluted Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.38
price down icon 0.39%
$97.03
price down icon 1.63%
$31.35
price down icon 0.70%
$92.23
price down icon 1.68%
biotechnology ONC
$304.31
price down icon 2.05%
$200.67
price up icon 1.90%
Capitalizzazione:     |  Volume (24 ore):